MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Clinical Trials Arena
MSD's Sac-TMT delivers in first phase 3 readout pharmaphorum
Merck reports positive Phase 3 results for uterine cancer drug Voice of Healthcare
Merck endometrial cancer drug meets survival goals in phase 3 trial StreetInsider
CT and international research team advances understanding of disease that impacts women worldwide Hartford Courant
Endometriosis is characterized by progressive fibrosis and limited therapeutic options. Cuproptosis, a copper-dependent form of regulated cell death, has been implicated in multiple pathological conditions, but its relevance to fibroblast-mediated …
To investigate the efficacy of different pretreatment protocols for women with endometriosis undergoing IVF. We systematically searched the Cochrane Library, PubMed, Medline, and Embase from inception to April 30, 2025, …
Endometriosis and adenomyosis are estrogen-dependent inflammatory conditions frequently associated with impaired fertility. Although progesterone resistance at the tissue level is well documented, it remains unclear whether these conditions are associated …
To develop a predictive risk score for superficial peritoneal endometriosis (SPE) in patients with negative examination and imaging based on symptoms and quality of life measures DESIGN: Multicenter nested case-control …
"The disease took everything from me": This athlete opens up about her battle against endometriosis MSN